Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: Longitudinal prospective cohort study

International Journal of Gynecological Cancer

Volumn 23, Issue 9, 2013, Pages 1717-1725

  Pieterse, Quirine D ^a   Kenter, Gemma G ^a,b   Maas, Cornelis P ^a   De Kroon, Cor D ^a   Creutzberg, Carien L ^a   Trimbos, J Baptist M J ^a   Ter Kuile, Moniek M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Centre for Gynaecological Oncology   (Netherlands)

Author keywords

Cervical cancer; Morbidity; Nerve sparing; Radical hysterectomy

Indexed keywords

ADULT; ARTICLE; BLADDER FUNCTION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DISTAL PARESTHESIA; DUTCH GYNAECOLOGIC LEIDEN QUESTIONNAIRE; EARLY CANCER; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; INTESTINE FUNCTION; LONGITUDINAL STUDY; LYMPHEDEMA; MAJOR CLINICAL STUDY; MORBIDITY; MULTIMODALITY CANCER THERAPY; NONHUMAN; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RADICAL HYSTERECTOMY; SELF REPORT; SEXUAL FUNCTION; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; URINE INCONTINENCE; UTERINE CERVIX CANCER;

ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTESTINES; LONGITUDINAL STUDIES; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; SELF REPORT; SEXUAL BEHAVIOR; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 84888342978     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182a80a65     Document Type: Article

References (25)

1. Avall-Lundqvist E, Dickman PW, et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999; 340: 1383-1389.
2. Pieterse QD, Maas CP, ter Kuile MM, et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer. 2006; 16: 1119-1129.
3. Zullo MA, Manci N, Angioli R, et al. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol. 2003; 48: 287-293.
4. Schultz WC, Van De Wiel HB. Sexuality, intimacy, and gynecological cancer. J Sex Marital Ther. 2003; 29: 121-128.
5. Sadovsky R, Basson R, Krygman M, et al. Cancer and sexual problems. J Sex Med. 2010; 7: 349-373.
6. Trimbos JB, Maas CP, DeRuiter MC, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. 2001; 11: 180-186.
7. Hockel M, Horn LC, Fritsch H. Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol. 2005; 6: 751-756.
8. Charoenkwan K, Srisomboon J, Suprasert P, et al. Nerve-sparing class III radical hysterectomy: a modified technique to spare the pelvic autonomic nerves without compromising radicality. Int J Gynecol Cancer. 2006; 16: 1705-1712.
9. Yabuki Y, Sasaki H, Hatakeyama N, et al. Discrepancies between classic anatomy and modern gynecologic surgery on pelvic connective tissue structure: harmonization of those concepts by collaborative cadaver dissection. Am J Obstet Gynecol. 2005; 193: 7-15.
10. Pieterse QD, Ter Kuile MM, Deruiter MC, et al. Vaginal blood flow after radical hysterectomy with and without nerve sparing. A preliminary report. Int J Gynecol Cancer. 2008; 18: 576-583.
11. Raspagliesi F, Ditto A, Fontanelli R. Nerve-sparing radical hysterectomy:a surgical technique for preserving the autonomic hypogastric nerve. Gynecol Oncol. 2004; 93: 307-314.
12. Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006; 102: 256-262.
13. Cibula D, Velechovska P, Sláma J, et al. Late morbidity following nerve-sparing radical hysterectomy. Gynecol Oncol. 2010; 116: 506-511.
14. Ditto A, Martinelli F, Borreani C, et al. Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study. Int J Gynecol Cancer. 2009; 19: 953-957.
15. Pieterse Q, Ter Kuile MM, Maas C, et al. The Gynaecologic Leiden Questionnaire: psychometric properties of a self-report questionnaire of sexual function and vaginal changes for gynaecological cancer patients. Psychooncology. 2008; 17: 681-689.
16. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974; 44: 265-272.
17. Jensen PT, Groenvold M, Klee MC, et al. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2003; 56: 937-949.
18. Eifel PJ, Levenback C, Wharton JT, et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1995; 32: 1289-1300.
19. Soderini A, Sardi J, Giaroli A. Nerve sparing radical hysterectomy for cervical cancer. Preliminary results. Int J GynecolCancer. 2006; 16: 695-763.
20. Chivers ML, Seto MC, Lalumiere ML, et al. Agreement of self-reported and genital measures of sexual arousal in men and women: a meta-analysis. Arch Sex Behav. 2010; 39: 5-56.
21. Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav. 2003; 32: 193-208.
22. Burri A, Rahman Q, Spector T. Genetic and environmental risk factors for sexual distress and its association with female sexual dysfunction. Psychol Med. 2011; 41: 2435-2445.
23. Trimbos JB, van den Tillaart SA, Maas CP, et al. The swift operation: a modification of the Leiden nerve-sparing radical hysterectomy. Gynecol Surg. 2008; 5: 193-198.
24. Morokoff PJ. Volunteer bias in the psychophysiological study of female sexuality. J Sex Res. 1986; 22: 35-51.
25. Flynn P, Kew F, Kisely SR. Interventions for psychosexual dysfunction in women treated for gynaecological malignancy. Cochrane Database Syst Rev. 2009:CD004708.